ST. PAUL, Minn.--(BUSINESS WIRE)--Synovis Life Technologies, Inc. (Nasdaq: SYNO), a diversified medical device company, announced today that Richard W. Kramp, president and chief executive officer, and Brett A. Reynolds, chief financial officer will present at the ROTH 23rd Annual OC Growth Stock Conference at 7 p.m. CT (5 p.m. PT) on Monday, March 14, 2011.
To access the webcast and view the accompanying slide presentation, go to the investors’ portion of the company’s website, www.synovislife.com, on the day of the presentation and click on the webcast icon. A replay of the webcast and slide presentation will be available beginning at 8 p.m. CT, (6 p.m. PT) Monday, March 14.
The Roth Capital Partners conference will be held at The Ritz-Carlton, Dana Point, Calif., March 13 to 16. The institutional investor conference will feature more than 400 small-cap public companies, including 100 companies based in China.
About Synovis Life Technologies
Synovis Life Technologies,
Inc., a diversified medical device company based in St. Paul, Minn.,
develops, manufactures and markets biological and mechanical products
used by several surgical specialties to facilitate the repair and
reconstruction of soft tissue damaged or destroyed by disease or injury.
The company’s products include implantable biomaterials for soft tissue
repair, devices for microsurgery and surgical tools – all designed to
reduce risks and/or facilitate critical surgeries, improve patient
outcomes and reduce healthcare costs. For additional information on
Synovis Life Technologies and its products, visit the company’s website
at www.synovislife.com.